Nhlbi trans-omics for precision medicine (topmed) for the centralized omics resource (core) - RNA-SEQ - 2024 task order
Active Awarded Last action
- Contract number
- 75N92024F00001
- Awardee
-
New York Genome Center, Inc. UEI WKPTJDWG2C68
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,689,991
Award facts
- Opportunity
-
- 75N92024R0272 Solicitation number
- Contract value 81% obligated
-
- $5,689,991.26 Current, with exercised options
- $7,001,570.38 Potential, with all options
- Completion date 70% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10013, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $4,529,520 | |
| Original award | $1,160,471 |
About this award
The National Heart Lung and Blood Institute issued a $7.0 million delivery order to New York Genome Center, Inc. on September 23, 2024, for RNA-sequencing services under the Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource Indefinite Delivery Contract.
The parent IDC, a $500 million single-award vehicle, funds centralized omics resource services in support of precision medicine research across the National Heart Lung and Blood Institute's portfolio. Performance is located in New York, NY, with an ultimate completion date of September 22, 2027. The order is firm fixed price with no set-aside.
In fiscal year 2024, the order generated $1 thousand in invoiced revenue across 35 contractor hours at a derived government-paid rate of $28.84 per hour. New York Genome Center performed all work through its own workforce with no subcontractor engagement reported.
Quick answers
Who was awarded contract 75N92024F00001?
75N92024F00001 was awarded to New York Genome Center, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 23, 2024.
How much is contract 75N92024F00001 worth?
The government has obligated $5,689,991 on 75N92024F00001. Its potential value, with all options, is $7,001,570.
Is contract 75N92024F00001 an order under another contract?
Yes. 75N92024F00001 is a delivery order under 75N92023D00016, an indefinite delivery contract.
Was contract 75N92024F00001 competed?
The extent of competition for 75N92024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award